DANIEL BRADBURY - 10 Jun 2022 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Greg Acosta, Attorney-in-fact
Issuer symbol
CSTL
Transactions as of
10 Jun 2022
Net transactions value
$0
Form type
4
Filing time
13 Jun 2022, 19:03:50 UTC
Previous filing
06 Jun 2022
Next filing
03 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Options Exercise $0 +830 $0.000000 830 10 Jun 2022 Direct
holding CSTL Common Stock 245,763 10 Jun 2022 By LLC F1
holding CSTL Common Stock 97,780 10 Jun 2022 By Daniel Bradbury Irrecovable Descendant's Trust F2
holding CSTL Common Stock 97,805 10 Jun 2022 By Annette Bradbury Irrecovable Descendant's Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSTL Restricted Stock Units Options Exercise $0 -830 -100% $0.000000* 0 10 Jun 2022 Common Stock 830 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F2 Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F3 Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F4 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F5 The RSUs vested in full on the one-year anniversary of the date of grant on June 10, 2022.